Skip to content

Evaluate the efficacy of Lauhadi Modaka in the management of Panduroga (Iron Deficiency Anaemia)

Randomized controlled clinical trial to evaluate the efficacy of Lauhadi Modaka in the management of Pandu(Iron deficiency Anaemia). - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078182
Enrollment
92
Registered
2024-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

CSMSS Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having symptoms such as Daurbalya,Akshikutshotha,Panduta Pindikodweshtan, Hrutspandana. 2. Patient having Hb% more than 7 and less than 12gm/dl in females. more than 8 & less than 13gm/dl in males.

Exclusion criteria

Exclusion criteria: 1.Pregnancy induced Anaemia. 2. Patients present with known case of Sickle cell Anemia, Megaloblastic Anemia, Aplastic Anemia, Pernicious Anemia. 3 .Patients present with known case of any bleeding disorders, Thrombocytopenia, Hemorrhoids, Thalesemia.

Design outcomes

Primary

MeasureTime frame
Subjective criteria:- 1.Daurbalya will reduce 2.Akshikutashotha will reduce 3.Panduta 4.Pindikodweshtan will reduce 5.Hrutaspandana will reduce Timepoint: 15th,30th,45 th day

Secondary

MeasureTime frame
Hb% MCH MCHC HCT MCV Haematocrit will be in normal limits Timepoint: 15,30th,45th day

Countries

India

Contacts

Public ContactDrKumud bahurupi

C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011

dr.amolb1986@gmail.com9960566536

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026